{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-046293","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.983363+00:00","generated_at":"2026-05-30T03:35:26.448555+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Joint Corp Q3 net loss $3.2M; guides down system-wide sales and new openings","bullets":["Revenue $30.2M (+2% YoY); net loss $3.2M vs $716K loss in Q3 2023, including $3.8M impairment.","Adjusted EBITDA fell to $2.4M from $2.9M; system-wide sales up 18% to $129.3M.","Guidance cut: system-wide sales now $525-535M (prior $530-545M); new franchised openings 55-60 (prior 60-75).","Total clinics 963 at Sept 30; sold 7 franchise licenses in Q3 vs 12 in Q3 2023.","Unrestricted cash $20.7M; $20M credit facility available through Feb 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-046293","json":"https://secwatch.observer/filing/0001628280-24-046293.json","markdown":"https://secwatch.observer/filing/0001628280-24-046293.md","text":"https://secwatch.observer/filing/0001628280-24-046293.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000162828024046293/0001628280-24-046293-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000162828024046293/jynt-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:35:26.448555+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}